This December, we invite our customers and prospective partners to join Catalent for an exclusive open house in Swindon during England’s most enchanting season. As the streets sparkle with festive lights and holiday spirit, you’ll step into a rare opportunity to see how Zydis® ODT, the world’s leading orally disintegrating tablet technology, continues to transform patient-centric drug delivery.
This one-day event provides direct access to Zydis® ODT, Catalent’s pioneering lyophilized tablet platform. With more than 35 commercial products launched and 1.5 billion doses produced annually, Zydis® sets the benchmark for ultra-rapid disintegration, faster onset of action, and improved compliance across diverse patient populations.
You’ll experience:
- Expert sessions on bioavailability, sublingual delivery, and patient-centric design
- A guided tour of our state-of-the-art Swindon facility to see Zydis® manufacturing in action
- High-level networking in an intimate setting, enhanced by Swindon’s festive charm
As an added benefit, every in-person attendee will receive a complimentary PBPK molecule assessment. This tailored analysis predicts pregastric absorption potential, helping you evaluate candidate molecules earlier, refine development strategy, and accelerate pathways to clinical and commercial success.
Swindon is highly accessible from London, with direct train services taking under one hour. This event combines scientific depth with seasonal atmosphere, offering a rare chance to see how Zydis® have the potential to transform molecules into therapies patients prefer.
We look forward to welcoming you to Catalent Swindon!